ADIPOQ and Cognitive impairment: Some reports indicate that adiponectin levels in the cerebral spinal fluid (CSF) are reduced in AD [3, 4], and plasma adiponectin levels predict cognitive decline and cortical thinning in mild cognitive impairment with beta‐amyloid pathology [5].